AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Istakar-MF 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Savsan Mediscience Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Istakar-MF 50/500 Tablet

Diabex Duo 50/500 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risk. Diabex Duo 50/500 may be used independently or with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health conditions, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing is crucial for effectiveness; discontinue only under medical supervision. Adherence to the prescribed diet and exercise plan is essential for diabetes control. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and throat irritation. Low blood sugar (hypoglycemia) is a potential side effect, especially when used with insulin or sulfonylureas; learn to recognize and manage this. This medication isn't suitable for everyone. Inform your physician of any pre-existing kidney, liver, heart, or pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or breastfeeding individuals require medical consultation. Interaction with other drugs is possible; disclose all medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Kidney function and blood sugar levels will be monitored throughout treatment.

Uses of Istakar-MF 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Istakar-MF 50/500 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Istakar-MF 50/500 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Istakar-MF 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Istakar-MF 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Istakar-MF 50/500 Tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

How Istakar-MF 50/500 Tablet works:

Istakar-MF 50/500, a dual-action tablet containing sitagliptin and metformin, improves blood glucose management. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Istakar-MF 50/500 Tablet and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Istakar-MF 50/500 Tablet during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Nursing mothers should likely avoid Istakar-MF 50/500 Tablets. Preliminary data in humans indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Istakar-MF 50/500 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Istakar-MF 50/500 tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Istakar-MF 50/500 Tablet :

Should you forget to take your Istakar-MF 50/500 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Istakar-MF 50/500 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Istakar-MF 50/500 Tablet

Istakar-MF 50/500 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin enhances insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Istakar-MF 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia and neurological issues, including numbness, tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Istakar-MF 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Istakar-MF 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Istakar-MF 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Yes, Istakar-MF 50/500 Tablet can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from high blood lactic acid levels. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Istakar-MF 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Istakar-MF 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients allergic to Istakar-MF 50/500 Tablet components or excipients should not use it. Its use is contraindicated in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Istakar-MF 50/500 tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Istakar-MF 50/500 Tablet. This occurs due to excessive blood lactic acid. Because it's rare, metformin is avoided in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Istakar-MF 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes, including balance problems (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Istakar-MF 50/500 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Istakar-MF 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Istakar-MF 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Istakar-MF 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA when linked to metformin), is a potential side effect of Istakar-MF 50/500 Tablet. This rare complication is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Istakar-MF 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplementation with vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Istakar-MF 50/500 Tablet
237
MRP 275
13% off